These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22589419)

  • 61. Bupropion for smoking cessation: a review.
    Tong EK; Carmody TP; Simon JA
    Compr Ther; 2006; 32(1):26-33. PubMed ID: 16785579
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors.
    Collins AC; Romm E; Wehner JM
    Brain Res Bull; 1990 Sep; 25(3):373-9. PubMed ID: 2292034
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [ABC of smoking cessation. Bupropion and other drugs in non-nicotine therapy].
    Roddy E
    Cas Lek Cesk; 2004; 143(12):863-5. PubMed ID: 15730222
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rate-dependent effects of bupropion on nicotine self-administration and food-maintained responding in rats.
    Stairs DJ; Dworkin SI
    Pharmacol Biochem Behav; 2008 Oct; 90(4):701-11. PubMed ID: 18602678
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of nicotine's ability to serve as a negative feature in a Pavlovian appetitive conditioning task in rats.
    Bevins RA; Wilkinson JL; Palmatier MI; Siebert HL; Wiltgen SM
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):470-81. PubMed ID: 16047193
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preexposure to nicotine alters the subsequent locomotor stimulant effects of bupropion in rats.
    Wilkinson JL; Palmatier MI; Bevins RA
    Nicotine Tob Res; 2006 Feb; 8(1):141-6. PubMed ID: 16497608
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interventions for preventing weight gain after smoking cessation.
    Parsons AC; Shraim M; Inglis J; Aveyard P; Hajek P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006219. PubMed ID: 19160269
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antidepressants for smoking cessation.
    Hughes JR; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2003; (2):CD000031. PubMed ID: 12804385
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo.
    Sidhpura N; Redfern P; Rowley H; Heal D; Wonnacott S
    Biochem Pharmacol; 2007 Oct; 74(8):1292-8. PubMed ID: 17678630
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Review of bupropion for smoking cessation.
    Richmond R; Zwar N
    Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Calcium-acting drugs modulate expression and development of chronic tolerance to nicotine-induced antinociception in mice.
    Damaj MI
    J Pharmacol Exp Ther; 2005 Nov; 315(2):959-64. PubMed ID: 16099928
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents.
    Burch JB; de Fiebre CM; Marks MJ; Collins AC
    Psychopharmacology (Berl); 1988; 95(4):452-8. PubMed ID: 3145516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
    Keating GM; Lyseng-Williamson KA
    Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Age-dependent differences in nicotine reward and withdrawal in female mice.
    Kota D; Martin BR; Damaj MI
    Psychopharmacology (Berl); 2008 Jun; 198(2):201-10. PubMed ID: 18338157
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of non-reported bupropion metabolites in human plasma.
    Connarn JN; Luo R; Windak J; Zhang X; Babiskin A; Kelly M; Harrington G; Ellingrod VL; Kamali M; McInnis M; Sun D
    Biopharm Drug Dispos; 2016 Dec; 37(9):550-560. PubMed ID: 27723114
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze test.
    Kruk M; Tendera K; Biała G
    Pharmacol Rep; 2011; 63(6):1372-82. PubMed ID: 22358085
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bupropion differentially alters the aversive, locomotor and rewarding properties of nicotine in CD-1 mice.
    Rauhut AS; Hawrylak M; Mardekian SK
    Pharmacol Biochem Behav; 2008 Oct; 90(4):598-607. PubMed ID: 18556053
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization and modulation of acute tolerance to nicotine in mice.
    Damaj MI; Welch SP; Martin BR
    J Pharmacol Exp Ther; 1996 Apr; 277(1):454-61. PubMed ID: 8613954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.